Amyloid Beta Peptide Is an Endogenous Negative Allosteric Modulator of Leptin Receptor | Zendy

Erika Cecon | Zendy; Tori Lhomme | Zendy; Tangui Maurice | Zendy; Marine Luka | Zendy; Min Chen | Zendy; Anisia Silva | Zendy; Joris Wauman | Zendy; Lennart Zabeau | Zendy; Jan Tavernier | Zendy; Vincent Prévot | Zendy; Julie Dam | Zendy; Ralf Jockers | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Amyloid Beta Peptide Is an Endogenous Negative Allosteric Modulator of Leptin Receptor

Author(s) -

Erika Cecon,

Tori Lhomme,

Tangui Maurice,

Marine Luka,

Min Chen,

Anisia Silva,

Joris Wauman,

Lennart Zabeau,

Jan Tavernier,

Vincent Prévot,

Julie Dam,

Ralf Jockers

Publication year - 2020

Publication title -

neuroendocrinology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.493

H-Index - 101

eISSN - 1423-0194

pISSN - 0028-3835

DOI - 10.1159/000508105

Subject(s) - allosteric regulation , leptin receptor , leptin , allosteric modulator , receptor , endocrinology , medicine , function (biology) , biology , microbiology and biotechnology , chemistry , biochemistry , obesity

Metabolic dysfunction is now recognized as a pivotal component of Alzheimer's disease (AD), the most common dementia worldwide. However, the precise molecular mechanisms linking metabolic dysfunction to AD remain elusive.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research